Literature DB >> 36044606

Early Life Trauma and Social Processing in HIV: The Role of Neuroendocrine Factors and Inflammation.

Leah H Rubin1, Deeya Bhattacharya, Joelle Fuchs, Abigail Matthews, Sarah Abdellah, Rebecca T Veenhuis, Scott A Langenecker, Kathleen M Weber, Hans P Nazarloo, Sheila M Keating, C Sue Carter, Pauline M Maki.   

Abstract

OBJECTIVE: Early life trauma (ELT) and HIV are associated with social processing deficits. In people with HIV (PWH), we examined whether facial emotion identification accuracy differs by ELT and whether neuroendocrine factors including cortisol, oxytocin (OT), and arginine vasopressin, and/or immune system measures play a role in the ELT-performance association.
METHODS: We used secondary data from the placebo condition of a pharmacologic challenge study in PWH. Presence of ELT was measured with the Childhood Trauma Questionnaire (at least moderate experiences of sexual, physical, and/or emotional abuse). Social processing was measured with the Facial Emotion Perception Test (FEPT). Salivary immune system measures and cortisol were sampled across a 5-hour study session. Blood was collected at study session start (12 pm ) to measure OT and arginine vasopressin. We examined the association of ELT with FEPT and five biological moderators (from principal components analysis of 12 biomarkers) of ELT-FEPT associations.
RESULTS: Of 58 PWH (42 men; mean [standard deviation] age = 33.7 [8.9] years), 50% endorsed ELT. ELT-exposed PWH demonstrated lower identification accuracy across all emotional expressions (unstandardized β [ B ] = 0.13; standard error [SE] = 0.05; p = .021, d = 0.63) and had higher OT levels compared with ELT-unexposed PWH ( t(1,56) = 2.12, p = .039; d = 0.57). For total accuracy, an OT/C-reactive protein factor moderated the ELT-FEPT association ( B = 0.14; SE = 0.05; p = .014); accuracy was lower in ELT-exposed PWH versus ELT-unexposed PWH when the factor was low but not when high. Similar results were obtained for fearful, neutral, and happy faces ( p values < .05). Regardless of ELT, a myeloid migration (MCP-1/MMP-9) factor was associated with reduced accuracy ( p values < .05).
CONCLUSIONS: Our pilot findings suggest that ELT may alter social processing in PWH, and OT and C-reactive protein may be a target for improving social processing in ELT-exposed PWH, and myeloid migration markers may be a target in PWH more generally.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Psychosomatic Society.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36044606      PMCID: PMC9553269          DOI: 10.1097/PSY.0000000000001124

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   3.864


  85 in total

1.  Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin.

Authors:  Angela Szeto; Philip M McCabe; Daniel A Nation; Benjamin A Tabak; Maria A Rossetti; Michael E McCullough; Neil Schneiderman; Armando J Mendez
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

2.  Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2015-05-16       Impact factor: 4.939

Review 3.  The functional profile of the human amygdala in affective processing: insights from intracranial recordings.

Authors:  Ryan J Murray; Tobias Brosch; David Sander
Journal:  Cortex       Date:  2014-06-19       Impact factor: 4.027

4.  Functional neuroanatomy of peripheral inflammatory physiology: A meta-analysis of human neuroimaging studies.

Authors:  Thomas E Kraynak; Anna L Marsland; Tor D Wager; Peter J Gianaros
Journal:  Neurosci Biobehav Rev       Date:  2018-07-29       Impact factor: 8.989

Review 5.  Psychological trauma and PTSD in HIV-positive women: a meta-analysis.

Authors:  E L Machtinger; T C Wilson; J E Haberer; D S Weiss
Journal:  AIDS Behav       Date:  2012-11

6.  Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity.

Authors:  Leah H Rubin; Li Yao; Sarah K Keedy; James L Reilly; Jeffrey R Bishop; C Sue Carter; Hossein Pournajafi-Nazarloo; Lauren L Drogos; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Scot K Hill; Wei Liao; Gong-Jun Ji; Su Lui; John A Sweeney
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

7.  HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

8.  Atypical autonomic regulation, auditory processing, and affect recognition in women with HIV.

Authors:  K J Heilman; E R Harden; K M Weber; M Cohen; S W Porges
Journal:  Biol Psychol       Date:  2013-06-17       Impact factor: 3.251

9.  Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Margret S H Harris; Scot K Hill; James L Reilly; John A Sweeney
Journal:  Schizophr Res       Date:  2013-03-07       Impact factor: 4.939

Review 10.  Developmental consequences of oxytocin.

Authors:  C Sue Carter
Journal:  Physiol Behav       Date:  2003-08
View more
  2 in total

1.  The Interaction of HIV With Mental Health in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Leah H Rubin; Robert H Paul
Journal:  Psychosom Med       Date:  2022-10-01       Impact factor: 3.864

Review 2.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.